Analyst Insights
Protara Therapeutics Inc (TARA) with a beta value of 1.35 appears to be a promising investment opportunity.
On Monday, Protara Therapeutics Inc (NASDAQ: TARA) was -3.36% drop from the session before settling in for the closing price of $2.98. A 52-week range